Skip to main content
Clinical Trials/ISRCTN49998633
ISRCTN49998633
Completed
Not Applicable

INtramyocardial application of STEM cells in combination with transmyocardial laser revascularisation in coronary artery bypass graft patients

Heinrich-Heine-University (Germany)0 sites40 target enrollmentJune 15, 2007

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Coronary artery bypass graft
Sponsor
Heinrich-Heine-University (Germany)
Enrollment
40
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 15, 2007
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Heinrich-Heine-University (Germany)

Eligibility Criteria

Inclusion Criteria

  • 1\. 18 years (male or female gender)
  • 2\. Presence of at least two vessel coronary artery disease with at least one vessel that is not amenable to CABG, according to the angiogram, this vessel must serve an area of viable myocardium
  • 3\. Area of interest defined as part of free left ventricular wall with reduced contractility as shown either in ventriculographia during angiography and/or preoperative echo
  • 4\. Demonstration of reduced perfusion in the area of interest by cardiac Magnetic Resonance Imaging (MRI) or Computed Tomography (CT)
  • 5\. Global ejection fraction greater than 15% and less than 35%
  • 6\. Signed informed consent

Exclusion Criteria

  • 1\. Any condition that in the belief of the treating physician prevents successful stem cell collection or application (e.g. systemic infection, puncture for stem cell collection impossible)
  • 2\. Any condition that may adversely affect bone marrow (such as malignancy or prior irradiation to the pelvic bone)
  • 3\. Mitral valve insufficiency greater than II
  • 4\. History of ventricular arrhythmia, not controlled by medication and/or Automatic Implantable Cardioverter Defibrillator (AICD) required
  • 5\. Need of additional heart surgery (i.e. valve replacement)
  • 6\. Emergency or salvage operation defined as within 48 hours of diagnosis
  • 7\. Evidence of left ventricular thrombus
  • 8\. Previous heart surgery within the last six months (excluding implantation of pacemaker)
  • 9\. History of symptomatic carotid disease (e.g. any Transient Ischaemic Attack \[TIA], Prolonged Ischaemic Neurological Deficit \[PRIND], stroke) within the last three months prior to study intervention
  • 10\. Increased Creatine Kinase (CK) (greater than three times normal) in patients with unstable angina

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Not Applicable
Intramyocardial Application of Stem Cells in combination with transmyocardial Laser Revascularisation (TMLR) in CABG Patients - INSTEM-TrialOther forms of chronic ischaemic heart diseaseMedDRA version: 70Level: LLTClassification code 10032058
EUCTR2005-004051-35-DEniversity Hospital Düsseldorf
Recruiting
Phase 1
Clinical trial to study the safety and efficacy of stem cell therapy in patients with severe ventricular dysfunctio
CTRI/2009/091/000590Frontier Lifeline PvtLtd90
Active, not recruiting
Phase 1
Stem cell therapy in heart failureIschemic heart disease and heart failureMedDRA version: 19.0Level: LLTClassification code 10019279Term: Heart failureSystem Organ Class: 100000004849Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
EUCTR2015-002929-19-DEDepartment of Cardiology, Rigshospitalet139
Active, not recruiting
Phase 1
Stem cell therapy in heart failureIschemic heart disease and heart failureMedDRA version: 19.0Level: LLTClassification code 10019279Term: Heart failureSystem Organ Class: 100000004849Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
EUCTR2015-002929-19-DKDepartment of Cardiology, Rigshospitalet138
Active, not recruiting
Phase 1
Stem cell therapy in heart failureIschemic heart disease and heart failureMedDRA version: 20.0Level: LLTClassification code 10019279Term: Heart failureSystem Organ Class: 100000011680Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
EUCTR2015-002929-19-PLDepartment of Cardiology, Rigshospitalet139